Good candidates are generally healthy adults whose growth hormone activity has declined with age and who want a physiologically guided approach
This classification allows legal sale without FDA approval for therapeutic claims
In traditional clinical trials, a "responder" is someone who loses at least 5% of their body weight within the first three to six months
Apart from blood, it is unknown whether BCG establishes residence in any organs and alters their glucose metabolism
This is very exciting for people like me, who have spent 20 to 30 years taking care of patients with this condition, said Arun Sanyal, M.D., director of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health
PlexusDx's Microdose GLP-1 Protocol ($129/mo) introduces semaglutide more gradually, allowing your body to adapt with less intense early side effects while you build tolerance